Penserra Capital Management LLC Inovio Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.99 - $7.46 $24,001 - $35,882	-4,810 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $322 - $436	45 Added 0.94%	4,810 $34,000
Q2 2021 Aug 12, 2021	BUY	$6.23 - $10.03 $498 - $802	80 Added 1.71%	4,765 $44,000
Q1 2021 May 13, 2021	BUY	$8.81 - $16.96 $6,519 - $12,550	740 Added 18.76%	4,685 $43,000
Q4 2020 Feb 12, 2021	BUY	$8.5 - $12.85 $21,360 - $32,292	2,513 Added 175.49%	3,945 $34,000
Q3 2020 Nov 13, 2020	BUY	$9.57 - $27.05 $13,704 - $38,735	1,432 New	1,432 $16,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $476M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.